Positioning for success in biopharma requires a self critical analysis of the risk and rewards among four categories of value differentiation. The Key question: How do you define yourself against competition?
Research has shown that organisations with a capabilities-based strategy deliver higher returns to shareholders. But to achieve this, management teams must go beyond traditional strategy development and ask them-selves some tough questions: How does the company truly create value?
An aging population, urbanisation, and growth in emerging markers have increased the burden on healthcare systems worldwide, For biopharma, that has translated to new customers and greater demand for medicine.
In the New Health Economy, portfolio management requires capturing synergies among multiple business units while still preserving the right level of autonomy.
© 2017 PwC. All rights reserved. PwC refers to the PwC network and/or one or more of its member firms, each of which is a separate legal entity. Please see www.pwc.com/structure for further details. Liability limited by a scheme approved under Professional Standards Legislation.